Novastep Launches biofit™ Allograft Bone Wedge System

Orangeburg, New York, Nov. 07, 2016 (GLOBE NEWSWIRE) — Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical technologies company specializing in the foot and ankle, today announced the release of their biofit™ Wedge System, which consists of a variety of size-specific, pre-shaped allograft bone wedges for both Evans and Cotton osteotomies and a dedicated trials instrumentation module.  The trials are designed to provide a method of assessing osteotomy spaces to assist in the selection of appropriate biofit™ allograft wedge implants.

Osteotomies are procedures in which bone is cut and then re-aligned, often with bone graft placed as a wedge to secure the new position. The Cotton osteotomy involves the medial cuneiform and is used to correct rotational deformities of the forefoot. The Evans osteotomy is a lengthening procedure for the calcaneus (heel bone), used most commonly for treating flatfeet. The company’s newly released biofit™ Wedge System allows for more efficient procedures by eliminating some of the measuring and shaping of the graft material that are frequently required. The biofit™ wedge implants are aseptically processed from human cancellous bone by means of the bioSTART® Tissue Process to provide an osteoconductive scaffolding matrix that permits bony in-growth.  The allografts are stored at ambient temperatures with a five-year shelf-life.

“The biofit™ Wedge System instrument trials and allograft implants are engineered specifically for Evans and Cotton osteotomy surgeries, permitting decreased O.R. time and eliminating significant harvest site morbidity and other possible complications that may result from autograft specimen removal at the donor site” said Wayne A. Hurst, DPM, FACFAS, owner and founder Foot Specialists of Cedar Park & Georgetown in Austin, Texas. Hurst added that “Choosing the correct size is greatly simplified because each implant has a corresponding trial that may be used prior to actual insertion of the implant at the osteotomy site.”  The trials are arranged in a compactly organized, ergonomically designed module.

Nick Zelensky, Novastep’s Vice President of Marketing further commented that “The biofit™ instrument module is fully compatible with all Novastep cleanSTART® instrumentation trays and may be easily interchanged with other instrument modules or added to them within the trays.”  The cleanSTART® trays feature intuitive layouts, interchangeable modules, light weight construction and space saving designs that eliminate the need for multiple, bulky containers.

The biofit™ Wedge System, and other key elements of Novastep’s portfolio will be featured at the upcoming 2016 Global Foot and Ankle Symposium in New York City on December 2 – 3, 2016.

About Novastep

Novastep is a global medical device company specializing in the design, development and commercialization of advanced technologies that treat conditions affecting the foot and ankle. The Company is focused on optimizing clinical efficiencies, inventory management and healthcare economics by transforming the way foot and ankle products are deployed and utilized in the surgical environment. Novastep has allied itself with a strategic network of key international opinion leaders to deliver breakthrough technologies, innovative services and compelling medical education programs to the foot and ankle community. Novastep’s portfolio, services and distribution platforms are uniquely positioned to address foot and ankle trauma, deformity corrections and Charcot fracture management.

For further information concerning this announcement and/or Novastep, Inc., send all inquiries to info@novasteportho.com or call 877.287.0795.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button